North America Agentic AI In Pharmaceuticals Market Size, Share & Industry Analysis Report By End User (Large Pharmaceutical Companies, and Small and Mid-Size Biotech Firms), By Deployment Mode (Cloud-Based, and Hybrid), By Application (Clinical-Trial Design and Recruitment, and Drug Discovery and Lead Identification), By Country Outlook and Forecast, 2026 - 2033

The North America Agentic AI In Pharmaceuticals Market is expected to reach USD 757.63 million by 2032, growing at a CAGR of 36.7% during 2026 - 2033.

The US market dominated the North America Agentic AI In Pharmaceuticals Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 841.8 million by 2033, growing at a CAGR of 36.3 % during the forecast period.

Advancements in machine learning, natural language processing, and autonomous agent architectures have transformed AI from a supportive analytical tool into a strategic operational partner across pharmaceutical ecosystems. Today, agentic AI is increasingly deployed throughout the pharmaceutical value chain, including drug discovery, clinical trial management, regulatory compliance, manufacturing optimization, and commercialization activities. The market benefits from a strong concentration of pharmaceutical companies, biotechnology firms, AI technology providers, research institutions, and supportive regulatory frameworks that continue to accelerate adoption across North America.

Pharmaceutical organizations are increasingly deploying autonomous AI systems to accelerate drug discovery, optimize clinical trial design, and improve research productivity. Evolving regulatory frameworks and AI governance initiatives are encouraging adoption of transparent, auditable, and compliance-focused AI systems capable of operating within highly regulated pharmaceutical environments.

End User Outlook

Based on End User, the market is segmented into Large Pharmaceutical Companies, Small and Mid-Size Biotech Firms, Contract Research Organizations, and Academic and Research Institutes.

The Large Pharmaceutical Companies market dominated the North America Agentic AI In Pharmaceuticals Market by End User in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 391.71 million by 2032, growing at a CAGR of 36.1% during the forecast period. The Small and Mid-Size Biotech Firms market is expected to witness a CAGR of 36% during (2026 - 2033).

Large pharmaceutical organizations are increasingly implementing agentic AI systems capable of autonomous reasoning, workflow automation, predictive modeling, and intelligent decision-making to strengthen research and development activities.

The Small and Mid-Size Biotech Firms segment recorded significant growth supported by increasing adoption of AI-powered drug discovery platforms, cloud-based AI solutions, and automated research tools designed to improve innovation productivity and reduce operational costs.

The Contract Research Organizations segment witnessed notable adoption driven by increasing implementation of agentic AI technologies across outsourced pharmaceutical research and clinical trial management operations. These organizations are utilizing AI-powered automation to improve patient recruitment, data analysis, and operational efficiency.

Deployment Mode Outlook

Based on Deployment Mode, the market is segmented into Cloud-Based, Hybrid, and On-Premise.

The Cloud-Based market dominated the North America Agentic AI In Pharmaceuticals Market by Deployment Mode in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 368.15 million by 2032, growing at a CAGR of 36.1% during the forecast period. The Hybrid market is expected to witness a CAGR of 37.4% during (2026 - 2033).

The Cloud-Based segment accounted for the largest revenue share in 2025 owing to increasing adoption of scalable cloud infrastructure capable of supporting pharmaceutical data processing, AI model training, and real-time analytics operations. Pharmaceutical companies increasingly prefer cloud-based agentic AI platforms due to operational flexibility, collaborative research capabilities, and lower infrastructure costs.

The Hybrid segment recorded significant growth due to increasing demand for deployment models that combine cloud scalability with on-premise security and operational control. Organizations are utilizing hybrid architectures to optimize sensitive data management while maintaining flexible AI operations.

Application Outlook

Based on Application, the market is segmented into Clinical-Trial Design and Recruitment, Drug Discovery and Lead Identification, Lead Optimization, Pharmacovigilance and Safety Monitoring, Pre-clinical Development, Manufacturing-Process Optimization, and Other Applications.

The Clinical-Trial Design and Recruitment segment garnered the highest revenue share in 2025 owing to increasing implementation of agentic AI systems to optimize trial planning, improve patient recruitment strategies, accelerate participant identification, and strengthen clinical trial efficiency.

The Drug Discovery and Lead Identification segment recorded significant growth supported by increasing adoption of AI-powered molecular analysis systems and predictive modeling platforms that accelerate drug target identification and compound discovery activities.

Free Valuable Insights: The Global Agentic AI in Pharmaceuticals Market will hit USD 2,418.1 Million billion by 2033, at a CAGR of 37.3%

Country Outlook

Based on Country, the market is segmented into US, Canada, Mexico, and Rest of North America.

The US market dominated the North America Agentic AI In Pharmaceuticals Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 600.33 million by 2032, growing at a CAGR of 36.3% during the forecast period. The Canada market is expected to witness a CAGR of 38.6% during (2026 - 2033).

The US dominated the North America Agentic AI in Pharmaceuticals Market in 2025 owing to its advanced pharmaceutical ecosystem, strong AI innovation capabilities, supportive regulatory environment, and significant investments in autonomous pharmaceutical intelligence platforms. Pharmaceutical companies increasingly deploy agentic AI solutions to optimize drug discovery, automate regulatory workflows, improve clinical trial management, and enhance operational efficiency.

Canada is witnessing substantial growth supported by government-backed AI initiatives, strong biomedical research capabilities, increasing adoption of AI-powered pharmaceutical innovation solutions, and expanding collaboration between pharmaceutical organizations and research institutions.

List of Key Companies Profiled

• InSilico Medicine
• Numerion Labs, Inc.
• BenevolentAI Group
• Shenzhen Jingtai Technology Co., Ltd. (XtalPi)
• Recursion Pharmaceuticals, Inc.
• Deep Genomics Incorporated
• Schrödinger, LLC
• Owkin Inc.
• PeptiDream Inc.
• Healx Limited

North America Agentic AI In Pharmaceuticals Market Report Segmentation

By End User

• Large Pharmaceutical Companies
• Small and Mid-Size Biotech Firms
• Contract Research Organizations
• Academic and Research Institutes

By Deployment Mode

• Cloud-Based
• Hybrid
• On-Premise

By Application

• Clinical-Trial Design and Recruitment
• Drug Discovery and Lead Identification
• Lead Optimization
• Pharmacovigilance and Safety Monitoring
• Pre-clinical Development
• Manufacturing-Process Optimization
• Other Application

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. North America Market
1.1 Market Overview
1.2 Key Factors Impacting Market
1.2.1 Market Drivers
1.2.2 Market Restraints
1.2.3 Market Opportunities
1.2.4 Market Challenges
1.2.5 Market Trends
1.2.6 State of Competition
1.2.7 Market Consolidation
1.2.8 Key Customer Criteria
1.3 Product Life Cycle
1.4 Segmentation By End User
1.4.1 Large Pharmaceutical Companies
1.4.2 Small and Mid-Size Biotech Firms
1.4.3 Contract Research Organizations
1.4.4 Academic and Research Institutes
1.5 Segmentation By Deployment Mode
1.5.1 Cloud-Based
1.5.2 Hybrid
1.5.3 On-Premise
1.6 Segmentation By Application
1.6.1 Clinical-Trial Design and Recruitment
1.6.2 Drug Discovery and Lead Identification
1.6.3 Lead Optimization
1.6.4 Pharmacovigilance and Safety Monitoring
1.6.5 Pre-clinical Development
1.6.6 Manufacturing-Process Optimization
1.6.7 Other Application
1.7 Segmentation By Country
1.7.1 US
1.7.1.1 Segmentation By End User
1.7.1.1.1 Large Pharmaceutical Companies
1.7.1.1.2 Small and Mid-Size Biotech Firms
1.7.1.1.3 Contract Research Organizations
1.7.1.1.4 Academic and Research Institutes
1.7.1.2 Segmentation By Deployment Mode
1.7.1.2.1 Cloud-Based
1.7.1.2.2 Hybrid
1.7.1.2.3 On-Premise
1.7.1.3 Segmentation By Application
1.7.1.3.1 Clinical-Trial Design and Recruitment
1.7.1.3.2 Drug Discovery and Lead Identification
1.7.1.3.3 Lead Optimization
1.7.1.3.4 Pharmacovigilance and Safety Monitoring
1.7.1.3.5 Pre-clinical Development
1.7.1.3.6 Manufacturing-Process Optimization
1.7.1.3.7 Other Application
1.7.2 Canada
1.7.2.1 Segmentation By End User
1.7.2.1.1 Large Pharmaceutical Companies
1.7.2.1.2 Small and Mid-Size Biotech Firms
1.7.2.1.3 Contract Research Organizations
1.7.2.1.4 Academic and Research Institutes
1.7.2.2 Segmentation By Deployment Mode
1.7.2.2.1 Cloud-Based
1.7.2.2.2 Hybrid
1.7.2.2.3 On-Premise
1.7.2.3 Segmentation By Application
1.7.2.3.1 Clinical-Trial Design and Recruitment
1.7.2.3.2 Drug Discovery and Lead Identification
1.7.2.3.3 Lead Optimization
1.7.2.3.4 Pharmacovigilance and Safety Monitoring
1.7.2.3.5 Pre-clinical Development
1.7.2.3.6 Manufacturing-Process Optimization
1.7.2.3.7 Other Application
1.7.3 Mexico
1.7.3.1 Segmentation By End User
1.7.3.1.1 Large Pharmaceutical Companies
1.7.3.1.2 Small and Mid-Size Biotech Firms
1.7.3.1.3 Contract Research Organizations
1.7.3.1.4 Academic and Research Institutes
1.7.3.2 Segmentation By Deployment Mode
1.7.3.2.1 Cloud-Based
1.7.3.2.2 Hybrid
1.7.3.2.3 On-Premise
1.7.3.3 Segmentation By Application
1.7.3.3.1 Clinical-Trial Design and Recruitment
1.7.3.3.2 Drug Discovery and Lead Identification
1.7.3.3.3 Lead Optimization
1.7.3.3.4 Pharmacovigilance and Safety Monitoring
1.7.3.3.5 Pre-clinical Development
1.7.3.3.6 Manufacturing-Process Optimization
1.7.3.3.7 Other Application
1.7.4 Rest of North America
1.7.4.1 Segmentation By End User
1.7.4.1.1 Large Pharmaceutical Companies
1.7.4.1.2 Small and Mid-Size Biotech Firms
1.7.4.1.3 Contract Research Organizations
1.7.4.1.4 Academic and Research Institutes
1.7.4.2 Segmentation By Deployment Mode
1.7.4.2.1 Cloud-Based
1.7.4.2.2 Hybrid
1.7.4.2.3 On-Premise
1.7.4.3 Segmentation By Application
1.7.4.3.1 Clinical-Trial Design and Recruitment
1.7.4.3.2 Drug Discovery and Lead Identification
1.7.4.3.3 Lead Optimization
1.7.4.3.4 Pharmacovigilance and Safety Monitoring
1.7.4.3.5 Pre-clinical Development
1.7.4.3.6 Manufacturing-Process Optimization
1.7.4.3.7 Other Application


Chapter 2. Company Snapshot
2.1 InSilico Medicine
2.1.1 Business Overview
2.1.2 Key Information
2.1.3 Company Focus
2.1.4 Strategic Insights
2.1.5 Strategy Deployed
2.1.6 Product & Service Portfolio
2.1.7 Capability Overview
2.1.8 Technology & Innovation Focus
2.1.9 Customers / End Users
2.1.10 Competitive Positioning
2.1.11 Key Differentiators
2.1.12 Portfolio Matrix
2.1.13 SWOT Analysis
2.1.14 Future Outlook
2.2 Numerion Labs, Inc.
2.2.1 Business Overview
2.2.2 Key Information
2.2.3 Company Focus
2.2.4 Strategic Insights
2.2.5 Strategy Deployed
2.2.6 Product & Service Portfolio
2.2.7 Capability Overview
2.2.8 Technology & Innovation Focus
2.2.9 Customers / End Users
2.2.10 Competitive Positioning
2.2.11 Key Differentiators
2.2.12 Portfolio Matrix
2.2.13 SWOT Analysis
2.2.14 Future Outlook
2.3 BenevolentAI Group
2.3.1 Business Overview
2.3.2 Key Information
2.3.3 Company Focus
2.3.4 Strategic Insights
2.3.5 Strategy Deployed
2.3.6 Product & Service Portfolio
2.3.7 Capability Overview
2.3.8 Technology & Innovation Focus
2.3.9 Customers / End Users
2.3.10 Competitive Positioning
2.3.11 Key Differentiators
2.3.12 Portfolio Matrix
2.3.13 SWOT Analysis
2.3.14 Future Outlook
2.4 Shenzhen Jingtai Technology Co., Ltd (XtalPi)
2.4.1 Business Overview
2.4.2 Key Information
2.4.3 Company Focus
2.4.4 Strategic Insights
2.4.5 Strategy Deployed
2.4.6 Product & Service Portfolio
2.4.7 Capability Overview
2.4.8 Technology & Innovation Focus
2.4.9 Customers / End Users
2.4.10 Competitive Positioning
2.4.11 Key Differentiators
2.4.12 Portfolio Matrix
2.4.13 SWOT Analysis
2.4.14 Future Outlook
2.5 Recursion Pharmaceuticals, Inc.
2.5.1 Business Overview
2.5.2 Key Information
2.5.3 Company Focus
2.5.4 Strategic Insights
2.5.5 Strategy Deployed
2.5.6 Product & Service Portfolio
2.5.7 Capability Overview
2.5.8 Technology & Innovation Focus
2.5.9 Customers / End Users
2.5.10 Competitive Positioning
2.5.11 Key Differentiators
2.5.12 Portfolio Matrix
2.5.13 SWOT Analysis
2.5.14 Future Outlook
2.6 Deep Genomics Incorporated
2.6.1 Business Overview
2.6.2 Key Information
2.6.3 Company Focus
2.6.4 Strategic Insights
2.6.5 Strategy Deployed
2.6.6 Product & Service Portfolio
2.6.7 Capability Overview
2.6.8 Technology & Innovation Focus
2.6.9 Customers / End Users
2.6.10 Competitive Positioning
2.6.11 Key Differentiators
2.6.12 Portfolio Matrix
2.6.13 SWOT Analysis
2.6.14 Future Outlook
2.7 Schrödinger, LLC
2.7.1 Business Overview
2.7.2 Key Information
2.7.3 Company Focus
2.7.4 Strategic Insights
2.7.5 Strategy Deployed
2.7.6 Product & Service Portfolio
2.7.7 Capability Overview
2.7.8 Technology & Innovation Focus
2.7.9 Customers / End Users
2.7.10 Competitive Positioning
2.7.11 Key Differentiators
2.7.12 Portfolio Matrix
2.7.13 SWOT Analysis
2.7.14 Future Outlook
2.8 Owkin Inc.
2.8.1 Business Overview
2.8.2 Key Information
2.8.3 Company Focus
2.8.4 Strategic Insights
2.8.5 Strategy Deployed
2.8.6 Product & Service Portfolio
2.8.7 Capability Overview
2.8.8 Technology & Innovation Focus
2.8.9 Customers / End Users
2.8.10 Competitive Positioning
2.8.11 Key Differentiators
2.8.12 Portfolio Matrix
2.8.13 SWOT Analysis
2.8.14 Future Outlook
2.9 PeptiDream Inc.
2.9.1 Business Overview
2.9.2 Key Information
2.9.3 Company Focus
2.9.4 Strategic Insights
2.9.5 Strategy Deployed
2.9.6 Product & Service Portfolio
2.9.7 Capability Overview
2.9.8 Technology & Innovation Focus
2.9.9 Customers / End Users
2.9.10 Competitive Positioning
2.9.11 Key Differentiators
2.9.12 Portfolio Matrix
2.9.13 SWOT Analysis
2.9.14 Future Outlook
2.10 Healx Limited
2.10.1 Business Overview
2.10.2 Key Information
2.10.3 Company Focus
2.10.4 Strategic Insights
2.10.5 Strategy Deployed 2.10.6 Product & Service Portfolio
2.10.7 Capability Overview
2.10.8 Technology & Innovation Focus
2.10.9 Customers / End Users
2.10.10 Competitive Positioning
2.10.11 Key Differentiators
2.10.12 Portfolio Matrix
2.10.13 SWOT Analysis
2.10.14 Future Outlook

List of Tables
TABLE 1 North America Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 2 Methodology for the research
TABLE 3 Key Factors Impacting Market
TABLE 4 Market Consolidation
TABLE 5 Key Customer Criteria
TABLE 6 Product Life Cycle
TABLE 7 North America Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 8 North America Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 9 North America Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 10 North America Lead Optimization Market, 2022 - 2033, USD Million
TABLE 11 North America Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 12 North America Other Application Market, 2022 - 2033, USD Million
TABLE 13 North America Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 14 North America Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 15 North America Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 16 North America Cloud-Based Market, 2022 - 2033, USD Million
TABLE 17 North America Hybrid Market, 2022 - 2033, USD Million
TABLE 18 North America On-Premise Market, 2022 - 2033, USD Million
TABLE 19 North America Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 20 North America Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 21 North America Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 22 North America Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 23 North America Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 24 Canada Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 25 Methodology for the research
TABLE 26 Key Factors Impacting Market
TABLE 27 Market Consolidation
TABLE 28 Key Customer Criteria
TABLE 29 Product Life Cycle
TABLE 30 Canada Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 31 Canada Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 32 Canada Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 33 Canada Lead Optimization Market, 2022 - 2033, USD Million
TABLE 34 Canada Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 35 Canada Other Application Market, 2022 - 2033, USD Million
TABLE 36 Canada Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 37 Canada Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 38 Canada Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 39 Canada Cloud-Based Market, 2022 - 2033, USD Million
TABLE 40 Canada Hybrid Market, 2022 - 2033, USD Million
TABLE 41 Canada On-Premise Market, 2022 - 2033, USD Million
TABLE 42 Canada Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 43 Canada Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 44 Canada Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 45 Canada Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 46 Canada Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 47 Mexico Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 48 Methodology for the research
TABLE 49 Key Factors Impacting Market
TABLE 50 Market Consolidation
TABLE 51 Key Customer Criteria
TABLE 52 Product Life Cycle
TABLE 53 Mexico Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 54 Mexico Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 55 Mexico Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 56 Mexico Lead Optimization Market, 2022 - 2033, USD Million
TABLE 57 Mexico Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 58 Mexico Other Application Market, 2022 - 2033, USD Million
TABLE 59 Mexico Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 60 Mexico Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 61 Mexico Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 62 Mexico Cloud-Based Market, 2022 - 2033, USD Million
TABLE 63 Mexico Hybrid Market, 2022 - 2033, USD Million
TABLE 64 Mexico On-Premise Market, 2022 - 2033, USD Million
TABLE 65 Mexico Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 66 Mexico Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 67 Mexico Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 68 Mexico Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 69 Mexico Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 70 United States Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 71 Methodology for the research
TABLE 72 Key Factors Impacting Market
TABLE 73 Market Consolidation
TABLE 74 Key Customer Criteria
TABLE 75 Product Life Cycle
TABLE 76 United States Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 77 United States Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 78 United States Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 79 United States Lead Optimization Market, 2022 - 2033, USD Million
TABLE 80 United States Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 81 United States Other Application Market, 2022 - 2033, USD Million
TABLE 82 United States Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 83 United States Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 84 United States Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 85 United States Cloud-Based Market, 2022 - 2033, USD Million
TABLE 86 United States Hybrid Market, 2022 - 2033, USD Million
TABLE 87 United States On-Premise Market, 2022 - 2033, USD Million
TABLE 88 United States Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 89 United States Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 90 United States Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 91 United States Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 92 United States Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
TABLE 93 Rest of North America Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
TABLE 94 Methodology for the research
TABLE 95 Key Factors Impacting Market
TABLE 96 Market Consolidation
TABLE 97 Key Customer Criteria
TABLE 98 Product Life Cycle
TABLE 99 Rest of North America Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
TABLE 100 Rest of North America Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
TABLE 101 Rest of North America Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
TABLE 102 Rest of North America Lead Optimization Market, 2022 - 2033, USD Million
TABLE 103 Rest of North America Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
TABLE 104 Rest of North America Other Application Market, 2022 - 2033, USD Million
TABLE 105 Rest of North America Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
TABLE 106 Rest of North America Pre-clinical Development Market, 2022 - 2033, USD Million
TABLE 107 Rest of North America Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
TABLE 108 Rest of North America Cloud-Based Market, 2022 - 2033, USD Million
TABLE 109 Rest of North America Hybrid Market, 2022 - 2033, USD Million
TABLE 110 Rest of North America On-Premise Market, 2022 - 2033, USD Million
TABLE 111 Rest of North America Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
TABLE 112 Rest of North America Academic and Research Institutes Market, 2022 - 2033, USD Million
TABLE 113 Rest of North America Contract Research Organizations Market, 2022 - 2033, USD Million
TABLE 114 Rest of North America Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
TABLE 115 Rest of North America Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million


List of Figures
FIG 1 Methodology for the research
FIG 2 Key Factors Impacting Market
FIG 3 Market Consolidation
FIG 4 Key Customer Criteria
FIG 5 Product Life Cycle
FIG 6 North America Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 7 North America Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 8 North America Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 9 North America Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 10 North America Lead Optimization Market, 2022 - 2033, USD Million
FIG 11 North America Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 12 North America Other Application Market, 2022 - 2033, USD Million
FIG 13 North America Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 14 North America Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 15 North America Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 16 North America Cloud-Based Market, 2022 - 2033, USD Million
FIG 17 North America Hybrid Market, 2022 - 2033, USD Million
FIG 18 North America On-Premise Market, 2022 - 2033, USD Million
FIG 19 North America Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 20 North America Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 21 North America Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 22 North America Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 23 North America Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 24 Canada Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 25 Canada Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 26 Canada Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 27 Canada Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 28 Canada Lead Optimization Market, 2022 - 2033, USD Million
FIG 29 Canada Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 30 Canada Other Application Market, 2022 - 2033, USD Million
FIG 31 Canada Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 32 Canada Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 33 Canada Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 34 Canada Cloud-Based Market, 2022 - 2033, USD Million
FIG 35 Canada Hybrid Market, 2022 - 2033, USD Million
FIG 36 Canada On-Premise Market, 2022 - 2033, USD Million
FIG 37 Canada Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 38 Canada Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 39 Canada Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 40 Canada Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 41 Canada Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 42 Mexico Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 43 Mexico Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 44 Mexico Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 45 Mexico Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 46 Mexico Lead Optimization Market, 2022 - 2033, USD Million
FIG 47 Mexico Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 48 Mexico Other Application Market, 2022 - 2033, USD Million
FIG 49 Mexico Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 50 Mexico Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 51 Mexico Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 52 Mexico Cloud-Based Market, 2022 - 2033, USD Million
FIG 53 Mexico Hybrid Market, 2022 - 2033, USD Million
FIG 54 Mexico On-Premise Market, 2022 - 2033, USD Million
FIG 55 Mexico Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 56 Mexico Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 57 Mexico Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 58 Mexico Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 59 Mexico Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 60 United States Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 61 United States Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 62 United States Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 63 United States Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 64 United States Lead Optimization Market, 2022 - 2033, USD Million
FIG 65 United States Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 66 United States Other Application Market, 2022 - 2033, USD Million
FIG 67 United States Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 68 United States Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 69 United States Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 70 United States Cloud-Based Market, 2022 - 2033, USD Million
FIG 71 United States Hybrid Market, 2022 - 2033, USD Million
FIG 72 United States On-Premise Market, 2022 - 2033, USD Million
FIG 73 United States Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 74 United States Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 75 United States Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 76 United States Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 77 United States Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million
FIG 78 Rest of North America Agentic AI In Pharmaceuticals Market Market, 2022 - 2033, USD Million
FIG 79 Rest of North America Agentic AI In Pharmaceuticals Market Market by Application, 2022 - 2033, USD Million
FIG 80 Rest of North America Clinical-Trial Design and Recruitment Market, 2022 - 2033, USD Million
FIG 81 Rest of North America Drug Discovery and Lead Identification Market, 2022 - 2033, USD Million
FIG 82 Rest of North America Lead Optimization Market, 2022 - 2033, USD Million
FIG 83 Rest of North America Manufacturing-Process Optimization Market, 2022 - 2033, USD Million
FIG 84 Rest of North America Other Application Market, 2022 - 2033, USD Million
FIG 85 Rest of North America Pharmacovigilance and Safety Monitoring Market, 2022 - 2033, USD Million
FIG 86 Rest of North America Pre-clinical Development Market, 2022 - 2033, USD Million
FIG 87 Rest of North America Agentic AI In Pharmaceuticals Market Market by Deployment Mode, 2022 - 2033, USD Million
FIG 88 Rest of North America Cloud-Based Market, 2022 - 2033, USD Million
FIG 89 Rest of North America Hybrid Market, 2022 - 2033, USD Million
FIG 90 Rest of North America On-Premise Market, 2022 - 2033, USD Million
FIG 91 Rest of North America Agentic AI In Pharmaceuticals Market Market by End User, 2022 - 2033, USD Million
FIG 92 Rest of North America Academic and Research Institutes Market, 2022 - 2033, USD Million
FIG 93 Rest of North America Contract Research Organizations Market, 2022 - 2033, USD Million
FIG 94 Rest of North America Large Pharmaceutical Companies Market, 2022 - 2033, USD Million
FIG 95 Rest of North America Small and Mid-Size Biotech Firms Market, 2022 - 2033, USD Million